SCHEMBL21675434

SCHEMBL21675434

C=C(CO)C(=O)OCCOc1cc(OCCOC(=O)C(=C)CO)cc(-c2ccc(C3CCCCC3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ NAAA Q02083 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ ASAH1 Q13510 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP2C9 P11712 1/20 0.34
▸ APP P05067 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ PPARG P37231 2/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ SLC6A7 Q99884 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23177209 0.91 PPARG (0.36) FFAR4HRH3KCNH2NAAACYP3A4
SCHEMBL22101097 0.89 HRH3 (0.35) FFAR4HRH3
SCHEMBL20313557 0.86 CYP2C9 (0.43) ALDH1A1MAPTCYP2C9KMT2APPARG
SCHEMBL19854210 0.84 DGAT1 (0.32) FFAR4CYP2C9
SCHEMBL19855964 0.84 DGAT1 (0.33) FFAR4CYP2C9
SCHEMBL19855372 0.83 FFAR4 (0.33) FFAR4CYP2C9
SCHEMBL20313614 0.83 CYP2C9 (0.41) ALDH1A1MAPTCYP2C9KMT2APPARG
SCHEMBL19854416 0.83 RAB9A (0.37) ALDH1A1MAPTCYP2C9
SCHEMBL19854219 0.82 RAB9A (0.37) ALDH1A1MAPTCYP2C9
SCHEMBL19855316 0.82 RAB9A (0.37) ALDH1A1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043781-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 — — US disclosed
US-11802243-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-10-31 — — US disclosed
US-20230295510-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-09-21 — — US disclosed
US-20230295511-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-09-21 — — US disclosed
US-11739267-B2 LC medium MERCK PATENT GMBH (DE) 2023-08-29 — — US disclosed
US-11739266-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-29 — — US disclosed
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20230242817-A1 LIQUID-CRYSTAL MEDIUM COMPRISING POYLMERIZABLE COMPOUNDS MERCK PATENT GMBH (DE) 2023-08-03 — — US disclosed
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-06-27 — — US disclosed
US-20230159825-A1 LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS MERCK PATENT GMBH (DE) 2023-05-25 — — US disclosed
US-11254872-B2 Liquid crystal media comprising polymerisable compounds MERCK PATENT GMBH (DE) 2022-02-22 — — US disclosed
US-20210348056-A1 Polymerisable Compounds and the Use thereof in Liquid-Crystal Displays MERCK PATENT GMBH (DE) 2021-11-11 — — US disclosed
US-20210222067-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2021-07-22 — — US disclosed
US-20210179942-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2021-06-17 — — US disclosed
US-20210139781-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2021-05-13 — — US disclosed
US-20210024826-A1 LIQUID-CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2021-01-28 — — US disclosed
US-20200407640-A1 LC MEDIUM MERCK PATENT GMBH (DE) 2020-12-31 — — US disclosed
US-20200339882-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2020-10-29 — — US disclosed
US-20200181493-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2020-06-11 — — US disclosed
US-20200040257-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2020-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 FFAR4 3100/4885HRH3 3602/4885KCNH2 1651/4885
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays LPXN, VCL, LCP1 FFAR4 2982/4885HRH3 4185/4885KCNH2 3257/4885
US-20210139781-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, ILK, LCP1 FFAR4 3100/4885HRH3 3602/4885KCNH2 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback